ArticleSignal transduction and targeted therapy2020

Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia.

Daniel A Luedtke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.